Quick Answer
Phio Pharmaceuticals Corp. reported Total Assets of $21.49 million for fiscal year 2025.
Phio Pharmaceuticals Corp. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $21.49M | +274.5% |
| 2024 | $5.74M | -38.7% |
| 2023 | $9.36M | -26.9% |
| 2022 | $12.81M | -49.1% |
| 2021 | $25.17M | +59.9% |
| 2020 | $15.74M | +95.8% |
| 2019 | $8.04M | -47.5% |
| 2018 | $15.32M | +273.9% |
| 2017 | $4.10M | -69.4% |
| 2016 | $13.40M | +20.1% |
| 2015 | $11.16M | +21.4% |
| 2014 | $9.19M | -38.5% |
| 2013 | $14.94M | +167.1% |
| 2012 | $5.59M | +230.1% |
| 2011 | $1.69M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.51M | +96.2% | +1.8% |
| June 30, 2025 | $11.30M | +113.4% | -15.9% |
| March 31, 2025 | $13.44M | +96.1% | +134.2% |
| December 31, 2024 | $5.74M | -38.7% | -2.2% |
| September 30, 2024 | $5.87M | -38.5% | +10.7% |
| June 30, 2024 | $5.30M | -56.9% | -22.7% |
| March 31, 2024 | $6.85M | -29.4% | -26.8% |
| December 31, 2023 | $9.36M | -26.9% | -1.8% |
- Phio Pharmaceuticals Corp. showed an increase of +274.5% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, Phio Pharmaceuticals Corp.’s total assets has grown by 1168.4% (from $1.69 million to $21.49 million).
- The most recent figure is from Phio Pharmaceuticals Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: